Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Use-Results Survey in Patients Infected With Hepatitis C Virus Genotype 2

NCT02945228 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02945228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02945228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Use-Results Survey in Patients Infected With Hepatitis C Virus Genotype 2
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
October 26, 2016
Completion date
July 26, 2019
Enrollment
449 (actual)
Sites
170

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c virus